← Open Payments lookup

THOMAS SHAVER: Open Payments

NPI 1790120137 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$595 in 12 payments from 7 companies in 2025. Trend: 2023 $660 · 2024 $815 · 2025 $595

Food & beverage: $595
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$150
Janssen Scientific Affairs, LLC1$149
Neurocrine BioSciences, Inc.1$149
E.R. Squibb & Sons, L.L.C.4$75
Teva Pharmaceuticals USA, Inc.1$29
ABBVIE INC.1$23
Otsuka America Pharmaceutical, Inc.1$21

Products named: CAPLYTA, INVEGA SUSTENNA, INGREZZA, COBENFY, UZEDY, VRAYLAR, REXULTI.

Industry payments across DC — which companies pay providers there.